258 related articles for article (PubMed ID: 30770239)
1. The RNase PARN Controls the Levels of Specific miRNAs that Contribute to p53 Regulation.
Shukla S; Bjerke GA; Muhlrad D; Yi R; Parker R
Mol Cell; 2019 Mar; 73(6):1204-1216.e4. PubMed ID: 30770239
[TBL] [Abstract][Full Text] [Related]
2. PARN Modulates Y RNA Stability and Its 3'-End Formation.
Shukla S; Parker R
Mol Cell Biol; 2017 Oct; 37(20):. PubMed ID: 28760775
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of telomerase RNA decay rescues telomerase deficiency caused by dyskerin or PARN defects.
Shukla S; Schmidt JC; Goldfarb KC; Cech TR; Parker R
Nat Struct Mol Biol; 2016 Apr; 23(4):286-92. PubMed ID: 26950371
[TBL] [Abstract][Full Text] [Related]
4. Poly(A)-specific ribonuclease (PARN) mediates 3'-end maturation of the telomerase RNA component.
Moon DH; Segal M; Boyraz B; Guinan E; Hofmann I; Cahan P; Tai AK; Agarwal S
Nat Genet; 2015 Dec; 47(12):1482-8. PubMed ID: 26482878
[TBL] [Abstract][Full Text] [Related]
5. Identification of PARN nuclease activity inhibitors by computational-based docking and high-throughput screening.
Huynh TN; Shukla S; Reigan P; Parker R
Sci Rep; 2023 Mar; 13(1):5244. PubMed ID: 37002320
[TBL] [Abstract][Full Text] [Related]
6. PAPD5-mediated 3' adenylation and subsequent degradation of miR-21 is disrupted in proliferative disease.
Boele J; Persson H; Shin JW; Ishizu Y; Newie IS; Søkilde R; Hawkins SM; Coarfa C; Ikeda K; Takayama K; Horie-Inoue K; Ando Y; Burroughs AM; Sasaki C; Suzuki C; Sakai M; Aoki S; Ogawa A; Hasegawa A; Lizio M; Kaida K; Teusink B; Carninci P; Suzuki H; Inoue S; Gunaratne PH; Rovira C; Hayashizaki Y; de Hoon MJ
Proc Natl Acad Sci U S A; 2014 Aug; 111(31):11467-72. PubMed ID: 25049417
[TBL] [Abstract][Full Text] [Related]
7. Poly(A)-specific ribonuclease sculpts the 3' ends of microRNAs.
Lee D; Park D; Park JH; Kim JH; Shin C
RNA; 2019 Mar; 25(3):388-405. PubMed ID: 30591540
[TBL] [Abstract][Full Text] [Related]
8. Disruption of Telomerase RNA Maturation Kinetics Precipitates Disease.
Roake CM; Chen L; Chakravarthy AL; Ferrell JE; Raffa GD; Artandi SE
Mol Cell; 2019 May; 74(4):688-700.e3. PubMed ID: 30930056
[TBL] [Abstract][Full Text] [Related]
9. The PARN, TOE1, and USB1 RNA deadenylases and their roles in non-coding RNA regulation.
Huynh TN; Parker R
J Biol Chem; 2023 Sep; 299(9):105139. PubMed ID: 37544646
[TBL] [Abstract][Full Text] [Related]
10. Regulation of poly(a)-specific ribonuclease activity by reversible lysine acetylation.
Dejene EA; Li Y; Showkatian Z; Ling H; Seto E
J Biol Chem; 2020 Jul; 295(30):10255-10270. PubMed ID: 32457045
[TBL] [Abstract][Full Text] [Related]
11. PARN deadenylase is involved in miRNA-dependent degradation of TP53 mRNA in mammalian cells.
Zhang X; Devany E; Murphy MR; Glazman G; Persaud M; Kleiman FE
Nucleic Acids Res; 2015 Dec; 43(22):10925-38. PubMed ID: 26400160
[TBL] [Abstract][Full Text] [Related]
12. Maturation of mammalian H/ACA box snoRNAs: PAPD5-dependent adenylation and PARN-dependent trimming.
Berndt H; Harnisch C; Rammelt C; Stöhr N; Zirkel A; Dohm JC; Himmelbauer H; Tavanez JP; Hüttelmaier S; Wahle E
RNA; 2012 May; 18(5):958-72. PubMed ID: 22442037
[TBL] [Abstract][Full Text] [Related]
13. AGO-bound mature miRNAs are oligouridylated by TUTs and subsequently degraded by DIS3L2.
Yang A; Shao TJ; Bofill-De Ros X; Lian C; Villanueva P; Dai L; Gu S
Nat Commun; 2020 Jun; 11(1):2765. PubMed ID: 32488030
[TBL] [Abstract][Full Text] [Related]
14. Dicer cooperates with p53 to suppress DNA damage and skin carcinogenesis in mice.
Lyle S; Hoover K; Colpan C; Zhu Z; Matijasevic Z; Jones SN
PLoS One; 2014; 9(6):e100920. PubMed ID: 24979267
[TBL] [Abstract][Full Text] [Related]
15. DICER1 regulated let-7 expression levels in p53-induced cancer repression requires cyclin D1.
Sun X; Tang SC; Xu C; Wang C; Qin S; Du N; Liu J; Zhang Y; Li X; Luo G; Zhou J; Xu F; Ren H
J Cell Mol Med; 2015 Jun; 19(6):1357-65. PubMed ID: 25702703
[TBL] [Abstract][Full Text] [Related]
16. RNA-binding protein AUF1 represses Dicer expression.
Abdelmohsen K; Tominaga-Yamanaka K; Srikantan S; Yoon JH; Kang MJ; Gorospe M
Nucleic Acids Res; 2012 Dec; 40(22):11531-44. PubMed ID: 23066106
[TBL] [Abstract][Full Text] [Related]
17. Posttranscriptional manipulation of TERC reverses molecular hallmarks of telomere disease.
Boyraz B; Moon DH; Segal M; Muosieyiri MZ; Aykanat A; Tai AK; Cahan P; Agarwal S
J Clin Invest; 2016 Sep; 126(9):3377-82. PubMed ID: 27482890
[TBL] [Abstract][Full Text] [Related]
18. MCPIP1 ribonuclease antagonizes dicer and terminates microRNA biogenesis through precursor microRNA degradation.
Suzuki HI; Arase M; Matsuyama H; Choi YL; Ueno T; Mano H; Sugimoto K; Miyazono K
Mol Cell; 2011 Nov; 44(3):424-36. PubMed ID: 22055188
[TBL] [Abstract][Full Text] [Related]
19. Destabilization of microRNAs in human cells by 3' deadenylation mediated by PARN and CUGBP1.
Katoh T; Hojo H; Suzuki T
Nucleic Acids Res; 2015 Sep; 43(15):7521-34. PubMed ID: 26130707
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of low DICER expression regulated by miR-130a in cervical cancer.
He L; Wang HY; Zhang L; Huang L; Li JD; Xiong Y; Zhang MY; Jia WH; Yun JP; Luo RZ; Zheng M
Cell Death Dis; 2014 May; 5(5):e1205. PubMed ID: 24787017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
